FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096758028> ?p ?o ?g. }

• W3096758028 endingPage "7208" @default.
• W3096758028 startingPage "7202" @default.
• W3096758028 abstract "Purpose: To investigate the effect of bone metastasis (BM) on survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with first-line tyrosine kinase inhibitors (TKI) by performing propensity-score matching (PSM) analysis. Materials & Methods: We retrospectively reviewed 1,151 patients with mRCC who were treated with first-line TKI from December 2006 to September 2016. After excluding 135 patients, 1,016 patients with mRCC were finally analyzed. The primary and secondary end points were overall survival (OS) and progression-free survival (PFS), respectively. After 1:1 PSM analysis, survival outcomes were compared between patients with BM (n=237) and without BM (n=237). Multivariate Cox regression analysis was used to determine predictors of survival. Results: Among 1,016 total patients, 27.5% (n=279) had BM. Before PSM, patients with BM had worse OS outcomes than those without BM. Even after PSM, OS was significantly poorer in patients with BM compared to those without BM. Of note, the presence of BM was identified as an independent predictor of OS (HR=1.36), in addition to prior nephrectomy, sarcomatoid differentiation, and IMDC risk group. However, there were no differences in PFS according to the presence of BM after PSM. In the subgroup analysis, only intermediate IMDC risk group showed significant differences in OS according to the presence of BM. Conclusion: Based on PSM analysis, the presence of BM negatively affected OS outcomes in patients with mRCC treated with first-line TKI, particularly in the IMDC intermediate risk group." @default.
• W3096758028 created "2020-11-09" @default.
• W3096758028 creator A5020377204 @default.
• W3096758028 creator A5026968692 @default.
• W3096758028 creator A5032056701 @default.
• W3096758028 creator A5034813693 @default.
• W3096758028 creator A5045648382 @default.
• W3096758028 creator A5055805396 @default.
• W3096758028 creator A5057146015 @default.
• W3096758028 creator A5062605231 @default.
• W3096758028 creator A5063110756 @default.
• W3096758028 creator A5068316401 @default.
• W3096758028 creator A5086895185 @default.
• W3096758028 date "2020-01-01" @default.
• W3096758028 modified "2023-10-13" @default.
• W3096758028 title "Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis" @default.
• W3096758028 cites W2069701490 @default.
• W3096758028 cites W2087324367 @default.
• W3096758028 cites W2099752220 @default.
• W3096758028 cites W2100366384 @default.
• W3096758028 cites W2107816359 @default.
• W3096758028 cites W2111378135 @default.
• W3096758028 cites W2150575159 @default.
• W3096758028 cites W2151355131 @default.
• W3096758028 cites W2155688313 @default.
• W3096758028 cites W2158903927 @default.
• W3096758028 cites W2462122250 @default.
• W3096758028 cites W2573038150 @default.
• W3096758028 cites W2735496645 @default.
• W3096758028 cites W2782594419 @default.
• W3096758028 cites W2801390849 @default.
• W3096758028 cites W2807529025 @default.
• W3096758028 cites W2807742259 @default.
• W3096758028 cites W2811337009 @default.
• W3096758028 cites W2889178940 @default.
• W3096758028 cites W2904455705 @default.
• W3096758028 cites W2912521988 @default.
• W3096758028 cites W2957649036 @default.
• W3096758028 cites W3003581883 @default.
• W3096758028 doi "https://doi.org/10.7150/jca.48062" @default.
• W3096758028 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7646162" @default.
• W3096758028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33193883" @default.
• W3096758028 hasPublicationYear "2020" @default.
• W3096758028 type Work @default.
• W3096758028 sameAs 3096758028 @default.
• W3096758028 citedByCount "2" @default.
• W3096758028 countsByYear W30967580282022 @default.
• W3096758028 countsByYear W30967580282023 @default.
• W3096758028 crossrefType "journal-article" @default.
• W3096758028 hasAuthorship W3096758028A5020377204 @default.
• W3096758028 hasAuthorship W3096758028A5026968692 @default.
• W3096758028 hasAuthorship W3096758028A5032056701 @default.
• W3096758028 hasAuthorship W3096758028A5034813693 @default.
• W3096758028 hasAuthorship W3096758028A5045648382 @default.
• W3096758028 hasAuthorship W3096758028A5055805396 @default.
• W3096758028 hasAuthorship W3096758028A5057146015 @default.
• W3096758028 hasAuthorship W3096758028A5062605231 @default.
• W3096758028 hasAuthorship W3096758028A5063110756 @default.
• W3096758028 hasAuthorship W3096758028A5068316401 @default.
• W3096758028 hasAuthorship W3096758028A5086895185 @default.
• W3096758028 hasBestOaLocation W30967580281 @default.
• W3096758028 hasConcept C121608353 @default.
• W3096758028 hasConcept C126322002 @default.
• W3096758028 hasConcept C126894567 @default.
• W3096758028 hasConcept C143998085 @default.
• W3096758028 hasConcept C170493617 @default.
• W3096758028 hasConcept C17923572 @default.
• W3096758028 hasConcept C187960798 @default.
• W3096758028 hasConcept C2777472916 @default.
• W3096758028 hasConcept C2779013556 @default.
• W3096758028 hasConcept C2780091579 @default.
• W3096758028 hasConcept C2780227381 @default.
• W3096758028 hasConcept C3019894029 @default.
• W3096758028 hasConcept C38180746 @default.
• W3096758028 hasConcept C42362537 @default.
• W3096758028 hasConcept C44249647 @default.
• W3096758028 hasConcept C50382708 @default.
• W3096758028 hasConcept C71924100 @default.
• W3096758028 hasConcept C90924648 @default.
• W3096758028 hasConceptScore W3096758028C121608353 @default.
• W3096758028 hasConceptScore W3096758028C126322002 @default.
• W3096758028 hasConceptScore W3096758028C126894567 @default.
• W3096758028 hasConceptScore W3096758028C143998085 @default.
• W3096758028 hasConceptScore W3096758028C170493617 @default.
• W3096758028 hasConceptScore W3096758028C17923572 @default.
• W3096758028 hasConceptScore W3096758028C187960798 @default.
• W3096758028 hasConceptScore W3096758028C2777472916 @default.
• W3096758028 hasConceptScore W3096758028C2779013556 @default.
• W3096758028 hasConceptScore W3096758028C2780091579 @default.
• W3096758028 hasConceptScore W3096758028C2780227381 @default.
• W3096758028 hasConceptScore W3096758028C3019894029 @default.
• W3096758028 hasConceptScore W3096758028C38180746 @default.
• W3096758028 hasConceptScore W3096758028C42362537 @default.
• W3096758028 hasConceptScore W3096758028C44249647 @default.
• W3096758028 hasConceptScore W3096758028C50382708 @default.
• W3096758028 hasConceptScore W3096758028C71924100 @default.
• W3096758028 hasConceptScore W3096758028C90924648 @default.
• W3096758028 hasIssue "24" @default.

• next